Fierce Biotech November 30, 2023
Several months after earning FDA clearance, a 3D-printed bone graft product is gaining steam, having now been used in a handful of surgical procedures.
The product in question is CMFlex, which was developed by Dimension Inx. It’s a synthetic bone graft material that’s customized to each individual patient and, once implanted, is designed to promote natural regeneration of the nearby bones.
CMFlex was cleared by the FDA in December 2022, making it the first 3D-printed regenerative bone graft product to earn a green light from the regulator. It’s indicated for use in surgeries to correct maxillofacial, mandibular and dental bone defects.
The synthetic material has now been used across all of those indications, according to an announcement this week from...
Today's Sponsors
Today's Sponsor